BeiGene, Ltd. (BGNE)
USD 184.71
(0.49%)
USD 184.71
(0.49%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 197.61 Million USD | -63.28% |
| 2022 | 538.11 Million USD | 119.5% |
| 2021 | 245.15 Million USD | 15.07% |
| 2020 | 213.05 Million USD | -20.06% |
| 2019 | 266.52 Million USD | 40.52% |
| 2018 | 189.67 Million USD | 21.98% |
| 2017 | 155.49 Million USD | 799.64% |
| 2016 | 17.28 Million USD | 179.31% |
| 2015 | 6.18 Million USD | -54.22% |
| 2014 | 13.51 Million USD | -11.3% |
| 2013 | 15.23 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 185.27 Million USD | -6.91% |
| 2024 Q1 | 199.02 Million USD | 0.71% |
| 2023 Q3 | 227.96 Million USD | -2.26% |
| 2023 Q4 | 197.61 Million USD | -13.31% |
| 2023 FY | 197.61 Million USD | -63.28% |
| 2023 Q1 | 238.84 Million USD | -55.62% |
| 2023 Q2 | 233.24 Million USD | -2.34% |
| 2022 Q3 | 244.96 Million USD | 7.85% |
| 2022 Q2 | 227.12 Million USD | -5.99% |
| 2022 Q1 | 241.59 Million USD | -1.45% |
| 2022 FY | 538.11 Million USD | 119.5% |
| 2022 Q4 | 538.11 Million USD | 119.67% |
| 2021 Q2 | 229.02 Million USD | 4.3% |
| 2021 Q4 | 245.15 Million USD | 2.78% |
| 2021 FY | 245.15 Million USD | 15.07% |
| 2021 Q1 | 219.58 Million USD | 3.06% |
| 2021 Q3 | 238.51 Million USD | 4.14% |
| 2020 Q1 | 272.15 Million USD | 2.11% |
| 2020 FY | 213.05 Million USD | -20.06% |
| 2020 Q4 | 213.05 Million USD | 18.21% |
| 2020 Q3 | 180.23 Million USD | -44.17% |
| 2020 Q2 | 322.82 Million USD | 18.61% |
| 2019 Q3 | 273.83 Million USD | 6.36% |
| 2019 Q4 | 266.52 Million USD | -2.67% |
| 2019 FY | 266.52 Million USD | 40.52% |
| 2019 Q1 | 252.19 Million USD | 32.97% |
| 2019 Q2 | 257.47 Million USD | 2.09% |
| 2018 Q1 | 164.11 Million USD | 5.55% |
| 2018 FY | 189.67 Million USD | 21.98% |
| 2018 Q4 | 189.67 Million USD | 1.3% |
| 2018 Q3 | 187.23 Million USD | -6.7% |
| 2018 Q2 | 200.68 Million USD | 22.28% |
| 2017 Q3 | 149.32 Million USD | -2.23% |
| 2017 Q1 | 17.43 Million USD | 0.87% |
| 2017 FY | 155.49 Million USD | 799.64% |
| 2017 Q4 | 155.49 Million USD | 4.13% |
| 2017 Q2 | 152.72 Million USD | 776.04% |
| 2016 FY | 17.28 Million USD | 179.31% |
| 2016 Q4 | 17.28 Million USD | -4.14% |
| 2016 Q2 | 10.55 Million USD | 69.83% |
| 2016 Q1 | 6.21 Million USD | 0.42% |
| 2016 Q3 | 18.03 Million USD | 70.85% |
| 2015 Q4 | 6.18 Million USD | -1.87% |
| 2015 Q2 | - USD | 0.0% |
| 2015 FY | 6.18 Million USD | -54.22% |
| 2015 Q1 | - USD | -100.0% |
| 2015 Q3 | 6.3 Million USD | 0.0% |
| 2014 Q4 | 13.51 Million USD | 0.0% |
| 2014 FY | 13.51 Million USD | -11.3% |
| 2013 FY | 15.23 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Absci Corporation | 4.66 Million USD | -4140.73% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -51.246% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 91.566% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -73914.232% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -991162.039% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 40.08 Million USD | -393.059% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -1665.865% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -96.443% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -945.875% |
| Chimerix, Inc. | 125 Thousand USD | -157994.4% |
| CRISPR Therapeutics AG | 223 Million USD | 11.385% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -2.595% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -3928.088% |
| Fortress Biotech, Inc. | 60.85 Million USD | -224.731% |
| Fortress Biotech, Inc. | 60.85 Million USD | -224.731% |
| Gritstone bio, Inc. | 40.14 Million USD | -392.273% |
| Allakos Inc. | 38.21 Million USD | -417.122% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | 20.192% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -432.965% |
| Cytokinetics, Incorporated | 607.37 Million USD | 67.463% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -2044.293% |
| Innoviva, Inc. | 446.23 Million USD | 55.714% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -750557.145% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -4332.885% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -1426.597% |
| ImmuCell Corporation | 10.54 Million USD | -1774.845% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -17466.044% |
| Incyte Corporation | 29.16 Million USD | -577.656% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -1691.305% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -145022.748% |
| Mustang Bio, Inc. | 1.97 Million USD | -9890.799% |
| MiMedx Group, Inc. | 48.09 Million USD | -310.857% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 30.19 Million USD | -554.451% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 5.3 Million USD | -3628.642% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -107.606% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 61.902% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -140.948% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -145207.353% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -270609.589% |
| NextCure, Inc. | 5.94 Million USD | -3221.869% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -18938.343% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 118.85 Thousand USD | -166165.344% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -136188.276% |
| Opthea Limited | 200.53 Million USD | 1.455% |
| Ovid Therapeutics Inc. | 30 Million USD | -558.727% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| PDS Biotechnology Corporation | 19.5 Million USD | -913.104% |
| Precigen, Inc. | 5.89 Million USD | -3252.299% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 4.35 Million USD | -4435.644% |
| PureTech Health plc | 18.25 Million USD | -982.838% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -785.147% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 92.689% |
| Replimune Group, Inc. | 71.99 Million USD | -174.508% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -275.286% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -515995.166% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -145.26% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -489.64% |
| Solid Biosciences Inc. | 23.94 Million USD | -725.438% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -33508.503% |
| SciSparc Ltd. | 24 Thousand USD | -823308.333% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -32.528% |
| TG Therapeutics, Inc. | 100.11 Million USD | -97.385% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -2912.01% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 47.618% |
| UroGen Pharma Ltd. | 98.55 Million USD | -100.524% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -360.927% |
| XOMA Corporation | 118.51 Million USD | -66.741% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -357.979% |
| AbCellera Biologics Inc. | 71.22 Million USD | -177.468% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -6001.899% |
| Precision BioSciences, Inc. | 7.72 Million USD | -2458.824% |
| Dyadic International, Inc. | 88.87 Thousand USD | -222267.503% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -143101.449% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -898163.636% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -199514.141% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -2338.223% |
| IGM Biosciences, Inc. | 34.67 Million USD | -469.964% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -262.137% |
| Acelyrin, Inc. | 1.19 Million USD | -16450.921% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -4389.278% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -3333.849% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -219173.445% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -662.798% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -471.878% |
| Senti Biosciences, Inc. | 33.53 Million USD | -489.236% |
| Mesoblast Limited | 100.48 Million USD | -96.668% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -152.292% |
| ChromaDex Corporation | 2.57 Million USD | -7574.485% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -177.569% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -661.123% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -3.502% |
| Novavax, Inc. | 168.01 Million USD | -17.619% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -102.977% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -247.344% |
| Celcuity Inc. | 37.03 Million USD | -433.592% |
| ContextLogic Inc. | 6 Million USD | -3193.633% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -42.887% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -5099.105% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 96.131% |
| Amarin Corporation plc | 8.73 Million USD | -2161.852% |
| AnaptysBio, Inc. | 16.03 Million USD | -1132.263% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -3561.627% |
| Aptorum Group Limited | 3.05 Million USD | -6361.272% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -2148.47% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -88.913% |
| Ardelyx, Inc. | 51.54 Million USD | -283.374% |
| Celularity Inc. | 26.17 Million USD | -654.93% |
| Omeros Corporation | 329.7 Million USD | 40.062% |
| Humacyte, Inc. | 38.6 Million USD | -411.964% |
| Immunocore Holdings plc | 82.64 Million USD | -139.12% |
| IO Biotech, Inc. | 1.83 Million USD | -10645.949% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -13454.047% |
| Summit Therapeutics Inc. | 103.29 Million USD | -91.323% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 8.32 Million USD | -2273.22% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -104.263% |
| Evogene Ltd. | 10.65 Million USD | -1755.046% |
| CorMedix Inc. | 517.01 Thousand USD | -38123.023% |
| BioLineRx Ltd. | 6.62 Million USD | -2881.563% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -12487.134% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 284.21 Million USD | 30.468% |
| scPharmaceuticals Inc. | 38.81 Million USD | -409.18% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -2190.161% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -691.612% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -1317353.333% |
| Lisata Therapeutics, Inc. | 137.00 USD | -144246615.328% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -4040.331% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -30681.62% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 3.91 Million USD | -4949.422% |
| bluebird bio, Inc. | 224.41 Million USD | 11.942% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 66.68% |
| DBV Technologies S.A. | 4.52 Million USD | -4266.284% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -3080.718% |
| Galecto, Inc. | 66 Thousand USD | -299321.212% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -5143.248% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -11409.493% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | 4.518% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -295540.596% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | 2.072% |
| ADMA Biologics, Inc. | 130.59 Million USD | -51.322% |
| Clene Inc. | 7.15 Million USD | -2663.115% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -17848.955% |
| Aptose Biosciences Inc. | 621 Thousand USD | -31722.544% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -19448.061% |
| Century Therapeutics, Inc. | 46.65 Million USD | -323.546% |
| Kura Oncology, Inc. | 9.33 Million USD | -2017.638% |
| Surrozen, Inc. | 882 Thousand USD | -22305.669% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -640.142% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -2005.679% |
| Autolus Therapeutics plc | 47.91 Million USD | -312.443% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -2817.732% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -662.768% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -758.276% |
| INmune Bio, Inc. | 397 Thousand USD | -49677.834% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -13.735% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -4774.33% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 30.99 Million USD | -537.621% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -134380.67% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -297.047% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -370.654% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -332.491% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 58.253% |
| Verastem, Inc. | 40.08 Million USD | -392.985% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -1865.566% |
| Histogen Inc. | 4.38 Million USD | -4407.71% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -313.427% |
| Surrozen, Inc. | 882 Thousand USD | -22305.669% |
| Organovo Holdings, Inc. | 888 Thousand USD | -22154.279% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -161.054% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -212155.113% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -678.667% |
| Turnstone Biologics Corp. | 1.18 Million USD | -16520.521% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -181200.917% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -227.611% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -140.971% |
| Exelixis, Inc. | 189.94 Million USD | -4.04% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -754.564% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -112.417% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -10794.046% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -28.663% |
| Insmed Incorporated | 1.19 Billion USD | 83.44% |
| MediWound Ltd. | 6.35 Million USD | -3012.094% |
| OmniAb, Inc. | 22.07 Million USD | -795.212% |
| Alector, Inc. | 30.45 Million USD | -548.864% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -94.613% |
| Zai Lab Limited | 8.04 Million USD | -2355.797% |
| AlloVir, Inc. | 16.64 Million USD | -1087.037% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 53.676% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -2648579.802% |
| Aura Biosciences, Inc. | 16.87 Million USD | -1071.417% |
| Immunic, Inc. | 639 Thousand USD | -30826.135% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -562.725% |
| Veracyte, Inc. | 7.52 Million USD | -2526.153% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 69.355% |
| FibroGen, Inc. | 89.69 Million USD | -120.317% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -4456.56% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -6098.808% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -150911.363% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -534002.703% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -9880.707% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 87.894% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -3185.42% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -10794.046% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -1370.481% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -42860.435% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -821.425% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -440.605% |
| Agenus Inc. | 137.32 Million USD | -43.906% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -38123.985% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -336.86% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -546.36% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -341.092% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 75.641% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -43907.723% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -200.528% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -62437.342% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -321250.982% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 5.92 Million USD | -3237.265% |
| Pluri Inc. | 29.05 Million USD | -580.198% |
| Prothena Corporation plc | 10.72 Million USD | -1743.28% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -895.507% |
| Rallybio Corporation | 173 Thousand USD | -114130.058% |
| Kodiak Sciences Inc. | 100 Million USD | -97.618% |
| Cue Biopharma, Inc. | 4.2 Million USD | -4602.951% |
| MeiraGTx Holdings plc | 72.11 Million USD | -174.017% |
| Annexon, Inc. | 29.19 Million USD | -577.006% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -17513.012% |
| Moderna, Inc. | - USD | -Infinity% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -12151.581% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -5424.685% |
| Blueprint Medicines Corporation | 610.96 Million USD | 67.655% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -360.895% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -305.92% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -677.901% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -117.399% |
| Elicio Therapeutics, Inc. | 6 Million USD | -3189.795% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -42036.034% |
| Nutriband Inc. | 79.82 Thousand USD | -247460.945% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -4307.181% |
| Vor Biopharma Inc. | 31.83 Million USD | -520.855% |
| Roivant Sciences Ltd. | 477.85 Million USD | 58.645% |
| Alkermes plc | 287.73 Million USD | 31.318% |
| ProKidney Corp. | 3.61 Million USD | -5374.183% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -25936.627% |
| Arcellx, Inc. | 50.84 Million USD | -288.698% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 88.615% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -436.451% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -175.46% |
| Atai Life Sciences N.V. | 15.21 Million USD | -1199.178% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -23359.233% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -77397.255% |
| MediciNova, Inc. | 410.66 Thousand USD | -48022.047% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -14335.208% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -29702.186% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -10.978% |
| Biomea Fusion, Inc. | 7.83 Million USD | -2423.857% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -9091.535% |
| Geron Corporation | 35.05 Million USD | -463.801% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -1615.136% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -770.756% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -1875.192% |
| Royalty Pharma plc | 6.13 Billion USD | 96.779% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -1617.671% |
| Imunon, Inc. | 1.13 Million USD | -17245.67% |
| BioAtla, Inc. | 836 Thousand USD | -23538.517% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -123.686% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -4096.602% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -753.715% |
| Structure Therapeutics Inc. | 4.01 Million USD | -4824.446% |
| 89bio, Inc. | 24.79 Million USD | -697.007% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -1862.638% |
| aTyr Pharma, Inc. | 13.76 Million USD | -1335.447% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -2401.81% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -878.065% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -70937.061% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -1267.139% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 86.819% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -98.595% |
| Liquidia Corporation | 2.36 Million USD | -8259.475% |
| Entera Bio Ltd. | 256 Thousand USD | -77094.531% |
| GH Research PLC | 631 Thousand USD | -31218.225% |
| Vericel Corporation | 81.85 Million USD | -141.422% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -2742.198% |
| Xencor, Inc. | 14.64 Million USD | -1249.665% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -131425.248% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -131645.333% |
| Vaxcyte, Inc. | 22.11 Million USD | -793.754% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -1957.663% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -2720.697% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -145022.748% |
| Portage Biotech Inc. | 7000.00 USD | -2823014.286% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -29702.186% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -13729.111% |
| OncoCyte Corporation | 2.2 Million USD | -8866.334% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -295271.049% |
| Purple Biotech Ltd. | 163 Thousand USD | -121138.037% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -3054.821% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -16286.235% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -40230.204% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -7695.582% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -41591.561% |
| United Therapeutics Corporation | 300 Million USD | 34.127% |
| HilleVax, Inc. | 25.24 Million USD | -682.832% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -18.972% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -21080.922% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -10564.76% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -883.223% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -650.03% |
| Windtree Therapeutics, Inc. | 15 Million USD | -1217.453% |
| Curis, Inc. | 1.48 Million USD | -13171.86% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -28223.599% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -3293533.333% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -280.848% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -14647.612% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -5146.031% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -21195.043% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -1031.379% |
| Adicet Bio, Inc. | 17.7 Million USD | -1016.297% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 49.049% |
| Aditxt, Inc. | 1.04 Million USD | -18869.92% |
| Adagene Inc. | 13.54 Million USD | -1359.509% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -1338.582% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -1056.134% |
| Compugen Ltd. | 719 Thousand USD | -27385.118% |
| Generation Bio Co. | 89.77 Million USD | -120.128% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -790.773% |
| Invivyd, Inc. | 722 Thousand USD | -27270.914% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -307.443% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -6759005.663% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -5066.484% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -859108.696% |
| 2seventy bio, Inc. | 244.01 Million USD | 19.013% |
| Instil Bio, Inc. | 81.42 Million USD | -142.693% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -5753.165% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -301657.547% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -75078.514% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -1950.192% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -76.961% |
| Evaxion Biotech A/S | 8.48 Million USD | -2227.999% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -163.754% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -205.367% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -3079.183% |
| Cingulate Inc. | 135.09 Thousand USD | -146176.434% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -739.534% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -109687.778% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -1033.326% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -21013.034% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -71.127% |
| ImmunityBio, Inc. | 836.95 Million USD | 76.388% |
| Korro Bio, Inc. | 31.21 Million USD | -533.066% |
| Kineta, Inc. | 150 Thousand USD | -131645.333% |
| BioVie Inc. | 349.89 Thousand USD | -56379.391% |
| Codexis, Inc. | 12.24 Million USD | -1514.131% |
| Celularity Inc. | 26.17 Million USD | -654.93% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -116.189% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -315.557% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -111963.285% |
| Cibus, Inc. | 17.67 Million USD | -1018.128% |
| IN8bio, Inc. | 3.37 Million USD | -5748.417% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -205.782% |
| Avalo Therapeutics, Inc. | 2 Million USD | -9780.9% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 85.888% |
| Eyenovia, Inc. | 8.95 Million USD | -2106.24% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -200.976% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | 30.13 Million USD | -555.732% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -2327.143% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -13454.047% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -830.493% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -18631.564% |
| Moolec Science SA | 99.04 Thousand USD | -199421.434% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -615.463% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -33337.902% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -11935.201% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -36769.03% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -622475.767% |
| Humacyte, Inc. | 38.6 Million USD | -411.964% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -1489.336% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -10490.461% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -19049.031% |
| Notable Labs, Ltd. | 1.52 Million USD | -12850.066% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -1338.582% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -62240.063% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -296.211% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -151913.846% |
| PepGen Inc. | 17.1 Million USD | -1055.661% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -4647.178% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -34089.965% |
| XOMA Corporation | 118.51 Million USD | -66.741% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -534002.703% |
| Bionomics Limited | 117.62 Million USD | -68.003% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -3422.602% |
| uniQure N.V. | 130.06 Million USD | -51.938% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -237.29% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -28707.289% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -4456.56% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -14168.448% |
| Altimmune, Inc. | 175 Thousand USD | -112824.571% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -3422.602% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -3800.869% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -133.715% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -1890.111% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -2997.946% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -1890.111% |
| argenx SE | 15.35 Million USD | -1187.078% |
| Immunome, Inc. | 1.34 Million USD | -14647.612% |
| Verona Pharma plc | 48.37 Million USD | -308.521% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -2044.293% |
| Shattuck Labs, Inc. | 3.4 Million USD | -5702.055% |
| CervoMed Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -232391.765% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -117529.762% |
| Moolec Science SA | 99.04 Thousand USD | -199421.434% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 2.33 Million USD | -8366.924% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Achilles Therapeutics plc | 1.07 Million USD | -18265.985% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -1520038.462% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 42.298% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -707.131% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -7804.752% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -101764.948% |
| Beam Therapeutics Inc. | 159.91 Million USD | -23.58% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | 35.508% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -23623.649% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -330243.352% |
| NeurAxis, Inc. | 27.07 Thousand USD | -729898.892% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -19661.8% |
| Lumos Pharma, Inc. | 6 Million USD | -3193.633% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -1080.342% |
| Palisade Bio, Inc. | 90 Thousand USD | -219475.556% |
| Nutriband Inc. | 79.82 Thousand USD | -247460.945% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -387.849% |
| Neurogene Inc. | 13.37 Million USD | -1377.739% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -652.458% |
| Athira Pharma, Inc. | 1.21 Million USD | -16138.127% |
| HCW Biologics Inc. | 6.3 Million USD | -3034.645% |
| XOMA Corporation | 118.51 Million USD | -66.741% |
| Nektar Therapeutics | 112.62 Million USD | -75.465% |
| Arvinas, Inc. | 800 Thousand USD | -24602.25% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -1267.139% |
| Merus N.V. | 10.48 Million USD | -1784.23% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -1227.632% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -1371.576% |
| Rezolute, Inc. | 1.66 Million USD | -11804.699% |
| Clene Inc. | 7.15 Million USD | -2663.115% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -269325.206% |
| BeyondSpring Inc. | 3.36 Million USD | -5774.495% |
| Synlogic, Inc. | 12.49 Million USD | -1482.083% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -505.151% |
| Krystal Biotech, Inc. | 6.62 Million USD | -2885.166% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -15.621% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -3195.831% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -417070.843% |
| MannKind Corporation | 252.15 Million USD | 21.627% |
| Ikena Oncology, Inc. | 7.18 Million USD | -2652.34% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -99205.528% |
| Gossamer Bio, Inc. | 197.4 Million USD | -0.108% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -37903.462% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | 29.755% |
| Mural Oncology plc | 8.91 Million USD | -2117.686% |
| Disc Medicine, Inc. | 1.43 Million USD | -13661.699% |
| Champions Oncology, Inc. | 6.09 Million USD | -3143.361% |
| REGENXBIO Inc. | 82.22 Million USD | -140.347% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -39903.401% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -4356.879% |
| Vaxart, Inc. | 2.62 Million USD | -7434.045% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -72652.374% |
| Cellectis S.A. | 36.24 Million USD | -445.288% |
| Longeveron Inc. | 1.44 Million USD | -13547.652% |
| Repare Therapeutics Inc. | 1.01 Million USD | -19466.139% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 82.551% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -341.417% |
| Revolution Medicines, Inc. | 80.57 Million USD | -145.26% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -6060.162% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -111548.588% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -160565.041% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 72.731% |
| Denali Therapeutics Inc. | 44.98 Million USD | -339.337% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -1480.407% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -146176.434% |
| Passage Bio, Inc. | 22.92 Million USD | -762.17% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -3172.363% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -30443.74% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -880.005% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -48400.333% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -16534.512% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -42307.296% |
| OmniAb, Inc. | 22.07 Million USD | -795.212% |
| Anew Medical, Inc. | 1.54 Million USD | -12732.338% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -568.532% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -2087.734% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -535.632% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -4774.33% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -283.3% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -3003.785% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1298.669% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -29307.44% |
| Alumis Inc. Common Stock | 30.86 Million USD | -540.369% |
| Equillium, Inc. | 384 Thousand USD | -51363.021% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -3108.605% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dominari Holdings Inc. | 3.02 Million USD | -6426.354% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -999333.571% |
| vTv Therapeutics Inc. | 169 Thousand USD | -116833.728% |
| Bio-Techne Corporation | 319 Million USD | 38.051% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -246.771% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -10.669% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -1182.651% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -1495.881% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -4011.046% |
| Nkarta, Inc. | 82.27 Million USD | -140.207% |
| BioCardia, Inc. | 982 Thousand USD | -20024.033% |
| Iterum Therapeutics plc | 18.95 Million USD | -942.509% |